nach oben

best practice onkologie

Erschienen in:

19.09.2014 | Topic

Therapie von Lungenmetastasen kolorektaler Karzinome

verfasst von: Prof. Dr. med. Erich Stoelben, Axel Gossmann, Tilman Steinmetz, Joachim Pfannschmidt

Erschienen in: best practice onkologie | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Lungenmetastasen treten im Rahmen von kolorektalen Karzinomen mit einer Häufigkeit von 1,5–2 % synchron bzw. 4–9 % metachron auf. Isolierte Lungenmetastasen machen davon etwa ein Drittel der Fälle aus. Eine radiologische Untersuchung der Lunge durch CT macht vor allem bei lokal fortgeschrittenen Tumoren Sinn. Der Ausschluss abdomineller Rezidive durch hochauflösende CT-Untersuchungen ist eine Voraussetzung für eine kurative Lungenmetastasenresektion, ausgenommen resektable Lebermetastasen. Kleine solitäre Lungenrundherde unter 1 cm Durchmesser sollten anhand von Algorithmen abgearbeitet werden.

[1]

Akiyoshi T, Oya M, Fujimoto Y et al (2009) Comparison of preoperative whole-body positron emission tomography with MDCT in patients with primary colorectal cancer. Colorectal Dis 11:464–469PubMedCrossRef

[2]

Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939–3945

[3]

Brandi G, Derenzini E, Falcone A et al (2013) Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. Clin Colorectal Cancer 12:188–194PubMedCrossRef

[4]

Chung CC, Hsieh CC, Lee HC et al (2011) Accuracy of helical computed tomography in the detection of pulmonary colorectal metastases. J Thorac Cardiovasc Surg 141:1207–1212PubMedCrossRef

[5]

Ding P, Liska D, Tang P et al (2012) Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study. Ann Surg 256:111–116PubMedCrossRef

[6]

Douillard JY, Oliner KS, Siena S et al (2013) Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med 369:1023–1034PubMedCrossRef

[7]

Eckardt J, Licht PB (2012) Thoracoscopic versus open pulmonary metastasectomy: a prospective, sequentially controlled study. Chest 142:1598–1602PubMedCrossRef

[8]

Floriani I, Torri V, Rulli E et al (2010) Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging 31:19–31PubMedCrossRef

[9]

Furukawa H, Ikuma H, Seki A et al (2006) Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer. Gut 55:1007–1011PubMedCrossRefPubMedCentral

[10]

Hirosawa T, Itabashi M, Ohnuki T et al (2013) Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: a multi-institutional cumulative follow-up study. Surg Today 43:494–499PubMedCrossRef

[11]

Kam MH, Wong DC, Siu S et al (2010) Comparison of magnetic resonance imaging-fluorodeoxy-glucose positron emission tomography fusion with pathological staging in rectal cancer. Br J Surg 97:266–268PubMedCrossRef

[12]

Llamas-Elvira JM, Rodriguez-Fernandez A, Gutierrez-Sainz J et al (2007) Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging 34:859–867PubMedCrossRef

[13]

Ludwig C, Cerinza J, Passlick B et al (2008) Comparison of the number of pre-, intra- and postoperative lung metastases. Eur J Cardiothorac Surg 33:470–472PubMedCrossRef

[14]

Mainenti PP, Mancini M, Mainolfi C et al (2010) Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticuloendothelial cell specific contrast agents. Abdom Imaging 35:511–521PubMedCrossRef

[15]

Mantke R, Schmidt U, Wolff S et al (2012) Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinicopathologic characteristics. Results of a German prospective multicentre observational study. Eur J Surg Oncol 38:259–265PubMedCrossRef

[16]

Marin C, Robles R, Lopez Conesa A et al (2013) Outcome of strict patient selection for surgical treatment of hepatic and pulmonary metastases from colorectal cancer. Dis Colon Rectum 56:43–50PubMedCrossRef

[17]

Martini N, Huvos AG, Mike V et al (1971) Multiple pulmonary resections in the treatment of osteogenic sarcoma. Ann Thorac Surg 12:271–280PubMedCrossRef

[18]

Miller G, Biernacki P, Kemeny NE et al (2007) Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 205:231–238PubMedCrossRef

[19]

Mitry E, Guiu B, Cosconea S et al (2010) Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year populationbased study. Gut 59:1383–1388PubMedCrossRef

[20]

Nakajima J, Murakawa T, Fukami T et al (2007) Is finger palpation at operation indispensable for pulmonary metastasectomy in colorectal cancer? Ann Thorac Surg 84:1680–1684PubMedCrossRef

[21]

Nakajima J, Murakawa T, Fukami T et al (2008) Is thoracoscopic surgery justified to treat pulmonary metastasis from colorectal cancer? Interact Cardiovasc Thorac Surg 7:212–216 (discussion 216-217)PubMedCrossRef

[22]

Neeff H, Horth W, Makowiec F et al (2009) Outcome after resection of hepatic and pulmonary metastases of colorectal cancer. J Gastrointest Surg 13:1813–1820PubMedCrossRef

[23]

Niekel MC, Bipat S, Stoker J (2010) Diagnostic imaging of colorectal liver Korrespondenzadresse metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a metaanalysis of prospective studies including patients who have not previously undergone treatment. Radiology 257:674–684PubMedCrossRef

[24]

Nordlinger B, Sorbye H, Glimelius B et al (2013) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14:1208–1215PubMedCrossRef

[25]

Parnaby C, Bailey W, Balasingam A et al (2012) Pulmonary staging in colorectal cancer: a review. Colorectal Dis 6:660–670CrossRef

[26]

Pfannschmidt J, Dienemann H, Hoffmann H (2007) Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 84:324–338PubMedCrossRef

[27]

Rafaelsen SR, Jakobsen A (2011) Contrast-enhanced ultrasound vs multidetector-computed tomography for detecting liver metastases in colorectal cancer: a prospective, blinded, patient-by-patient analysis. Colorectal Dis 13:420–425PubMedCrossRef

[28]

Riquet M, Foucault C, Cazes A et al (2010) Pulmonary resection for metastases of colorectal adenocarcinoma. Ann Thorac Surg 89:375–380PubMedCrossRef

[29]

Salah S, Watanabe K, Welter S et al (2012) Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model. Ann Oncol 23:2649–2655PubMedCrossRef

[30]

Salama JK, Kirkpatrick JP, Yin FF (2012) Stereotactic body radiotherapy treatment of extracranial metastases. Nature reviews. Clin Oncol 9:654–665

[31]

Schlijper RC, Grutters JP, Houben R et al (2014) What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation? Cancer Treat Rev 40:60–67PubMedCrossRef

[32]

Schmoll HJ, Van Cutsem E, Stein A et al (2012) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol 23:2479–2516PubMedCrossRef

[33]

Stoelben E, Koryllos A, Gossmann A (2013) The small lung nodule: dealing with a frequent radiological finding. Zentrabl Chir 138(Suppl 1):S6–S10CrossRef

[34]

Tan KK, Lopes Gde L Jr, Sim R (2009) How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years. J Gastrointest Surg 13:642–648PubMedCrossRef

[35]

Watanabe K, Saito N, Sugito M et al (2013) Incidence and predictive factors for pulmonary metastases after curative resection of colon cancer. Ann Surg Oncol 20:1374–1380PubMedCrossRef

[36]

Welter S, Jacobs J, Krbek T et al (2007) Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg 31:167–172PubMedCrossRef

Titel: Therapie von Lungenmetastasen kolorektaler Karzinome
verfasst von: Prof. Dr. med. Erich Stoelben
Axel Gossmann
Tilman Steinmetz
Joachim Pfannschmidt
Publikationsdatum: 19.09.2014
Verlag: Springer-Verlag
Erschienen in: best practice onkologie / Ausgabe 5/2014
Print ISSN: 0946-4565
Elektronische ISSN: 1862-8559
DOI: https://doi.org/10.1007/s11654-014-0513-2

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Therapie von Lungenmetastasen kolorektaler Karzinome

Zusammenfassung

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Diagnoseirrtum, Diagnosefehler, Befunderhebungsfehler

Krebs und Ernährung; Risiken und Prävention - wissenschaftliche Grundlagen und Ernährungsempfehlungen

Test weist Lungenkrebs-typische Genmutationen im Blut nach

Wie Tumore sich anpassen

Spätfolgen onkologischer Therapie

Psychoonkologische Beratungsstellen der Deutschen Krebsgesellschaft e. V.

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie